Document Detail


Apocynin improves the efficacy of secretory leukocyte protease inhibitor in experimental emphysema.
MedLine Citation:
PMID:  7952625     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Secretory leukocyte protease inhibitor (SLPI) is a potent proteinase inhibitor produced in the lung. Stimulated neutrophils at sites of inflammation can inactivate SLPI by myeloperoxidase-mediated oxidation of the methionine residue in the active site of SLPI. Apocynin is a selective inhibitor of NADPH oxidase and may therefore protect SLPI against neutrophil-mediated oxidative inactivation. The aim of the present study was to determine the effect of apocynin on the efficacy of SLPI in preventing experimental emphysema. To investigate the effect of apocynin on emphysema without SLPI treatment, three groups of eight hamsters each received drinking water containing apocynin at concentrations of 2, 20, and 200 micrograms/ml, respectively. Emphysema was induced in these hamsters by intratracheal instillations of 500 micrograms of lipopolysaccharide (LPS) twice a week for 4 wk. In hamsters that received 200 micrograms/ml apocynin, the development of emphysema was reduced by 26.2% (p = 0.01). Other apocynin concentrations had no effect. The experiment was repeated, with SLPI added to the treatment. Of a total of six groups of hamsters, four groups (three with apocynin and one with solvent) received twice-weekly doses of a mixture of 500 micrograms of LPS and 1 mg SLPI in 200 microliters saline in the trachea for 4 wk. In addition, each LPS instillation was followed 24 and 48 h later by an instillation containing 1 mg of SLPI. Apocynin (20 and 200 micrograms/ml) improved the protective effect of SLPI from 37 to 64% and 79%, respectively (p < 0.01). We conclude that oral administration of apocynin can improve the efficacy of SLPI in preventing LPS-induced emphysema.
Authors:
J Stolk; W Rossie; J H Dijkman
Related Documents :
18310625 - Effects of activated protein c on the mesenteric microcirculation and cytokine release ...
16474095 - Bactericidal function of alveolar macrophages in mechanically ventilated rabbits.
24301685 - Dosing of enoxaparin for venous thromboembolism prophylaxis in obese patients.
11408555 - Chronic lipopolysaccharide exposure on airway function, cell infiltration, and nitric o...
2942065 - Effect of zearalenone on the fertility of virgin dairy heifers.
12139205 - Alfuzosin, an alpha1-adrenoceptor antagonist for the treatment of benign prostatic hype...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of respiratory and critical care medicine     Volume:  150     ISSN:  1073-449X     ISO Abbreviation:  Am. J. Respir. Crit. Care Med.     Publication Date:  1994 Dec 
Date Detail:
Created Date:  1994-12-28     Completed Date:  1994-12-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421642     Medline TA:  Am J Respir Crit Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1628-31     Citation Subset:  AIM; IM    
Affiliation:
Department of Pulmonology, University Hospital Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetophenones / administration & dosage*
Administration, Oral
Animals
Cricetinae
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Drug Synergism
Lipopolysaccharides
Mesocricetus
NADH, NADPH Oxidoreductases / antagonists & inhibitors*
NADPH Oxidase
Proteinase Inhibitory Proteins, Secretory
Proteins*
Pulmonary Emphysema / chemically induced,  prevention & control*
Recombinant Proteins / administration & dosage
Serine Proteinase Inhibitors / administration & dosage*
Chemical
Reg. No./Substance:
0/Acetophenones; 0/Lipopolysaccharides; 0/Proteinase Inhibitory Proteins, Secretory; 0/Proteins; 0/Recombinant Proteins; 0/Serine Proteinase Inhibitors; 498-02-2/acetovanillone; EC 1.6.-/NADH, NADPH Oxidoreductases; EC 1.6.3.1/NADPH Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oxygen improves maximal exercise performance in interstitial lung disease.
Next Document:  Hypertonic saline challenge in an epidemiologic survey of asthma in children.